Delivery Order SPE2DB25D3017-SPE2DB25FVHKC

Award Date 3/20/25
Potential Completion Date 3/21/25
Potential Value $42K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,879.98 and is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $34,877.18, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of March 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,851.75 and provides for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a specialty pharmaceutical product. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $5,289.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,595.93, is a Firm Fixed Price Delivery Order for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,361.21 firm fixed-price delivery order is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication. The contract has an ultimate completion date of March 10, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $2,159.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order against an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,703.74, is a delivery order issued by the Defense Logistics Agency (DLA) for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication. The contract has an ultimate completion date of March 4, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,549.90 firm fixed-price delivery order is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used to treat diabetes. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,040.26, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract has an ultimate completion date of December 21, 2023. This award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the...
  • SPE2DB25D3017
    Indefinite Delivery Contract
  • SPE2DB25D3017-SPE2DB25FVHKC
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $41,941.29 and is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026.

The contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The award is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen has a long-standing relationship with the DLA, holding multiple IDCs to provide a wide range of pharmaceutical and medical supplies to support military healthcare programs globally. This contract award demonstrates the company's critical role in delivering essential medical commodities to federal government agencies.

Generated 6/21/25, 9:45 AM